| |
| Comments |
| Through my 40 years
experience at pharmaceutical company and its group (Sankyo Co.
Ltd., and Sankyo Chemical Industries Ltd.) in Japan, mainly
new drug research and development, process chemistry and
R&D tasks in America and Europe totally 8 years, I would
like to assist and cooperate such developing, expanding and
growing companies especially young and small scale companies
in the field of organic synthesis and pharmaceutical section.
I am happy if my experience and suggestion are effective and
make benefits to my clients. |
| Current
Performance |
Lecture: 2006; 7 times, 2007; 10 times,
2008; 7 times, 2009; 15 times
Consultation; A few pharmaceutical companies related with scale
up, trouble shooting, GMP, contract manufacturing, static
electricity, exothermic reaction. |
| Entitlement |
| Doctorate of Science,
Pharmacist |
| Area of Specialization |
Pharmaceutical, Organic synthesis, Process
Chemistry, Globalization of pharmaceutical companies and key
points of contract manufacturers, GMP
|
| Lectures & Writing |
| July 2005 |
The Japan Society for Process Chemistry,
Summer Symposium, Invited Lecturer |
| |
“Process Development of L-DOPA
as anti- Parkinson Disease“ |
| October 2005 |
Technical
Information Institute Co. Ltd. Seminar |
| |
“Scale up of Process Development
in the Field of Medicines and its Intermediates” |
December 2005
|
The Society of
Separation Process Engineer, Symposium Invited
Lecturer |
| |
“Process Development of L-DOPA
as anti-Parkinson Disease” |
| April 2006 |
CPhI
Japan, Symposium Invited Lecturer |
| |
“Pharmaceutical Company in Japan
under Globalization ; Challenges and Prospects of Custom
Synthesis Business” |
| May 2006 |
Science &
Technology Co. Ltd., Seminar |
| |
“Scale up of Process Development
in the Field of Medicines and its Intermediates ; How to
Dissolve the Troubles” |
| June 2006 |
Technical Information Institute
Co. Ltd., Seminar |
| |
“Scale up of Process Development
in the Field of Medicines and its Intermediates; How to
Dissolve the Troubles” |
| September 2006 |
Technical Information Institute
Co. Ltd., Seminar |
| |
“How to Manage Laboratory Notes
under Research & Development; Response to Problems
Involving Process Chemistry and GMP” |
| November 2006 |
Technical Information Institute
Co. Ltd., Seminar |
| |
“Scale up of Process Development
in the Field of Medicines and its Intermediates; How to
Minimize its Careless Failure and Avoid Disaste” |
| February 2007 |
Science & Technology C.
Ltd., Under Publication |
| |
“Process
Chemistry” |
| February 2007 |
“Scale-up methods of Batch process
in the laboratories”. Published by Science & Technology Ltd., |
| April 2008 |
“Scale-up and trouble shooting in
the field of pharmaceuticals and intermediates”. Published by
CMC Publication Ltd. |
| November 2008 |
“Globalization of Pharmaceutical
Companies and GMP”. Published by CMC Publication Ltd. |
| December 2009 |
“Scale-up Points of
Pharmaceuticals and Drugs”. Published by Jyoho Kikou Ltd. |
| January 2009 |
CPhI Japan Seminar
“Globalization of Pharmaceutical companies and tasks of contract
manufacturers”. |
| May 2009 |
Toho University Open Seminar
Lecturer
“Relation between Shape and Effectiveness of Medicine” |
| July 2009 |
Interfex Japan, Special Lecturer
“Scale up and Trable shooting in the field of Pharmaceuticals
development” |
| Academic Career |
| March 1964 |
Graduated Kyushu University
Medicinal Department |
| March 1966 |
Graduated Kyushu University,
Pharmaceutical Dept. Master Degree |
| April 1966 |
Sankyo
Co. Ltd., Started Research of Process Chemistry |
April 1970
〜March 1973 |
Reseach Fellow at Tokyo Institute of
Technology, Professor Mukaiyama |
September 1976
〜 August
1977 |
Post Doctoral at M.I.T., Professor
Sidony Hecht |
September 1977
〜 August
1978 |
Post Doctoral at U.C.I. Professor
Larry E. Overman |
| July 1989 |
Sankyo International Dept. |
| July 1999 |
Sankyo Chemical Industries Ltd., Product
Development Dept. |
| June 2002 |
Managing Director of
R&D |
| June 2006 |
Retirement |
| October 2006 |
Pharma Research Consulting
Office, President |
| October 2006 |
Pharma Research Consulting Office,
set up as a President | |
